Sort   by:  
 Page size 
UnknownBRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study.
Not available
S-EPMC6286161 | biostudies-literature
GenomicsSame-day genomic and epigenomic diagnosis of brain tumors using realtime nanopore sequencing
Molecular classification of cancer has entered clinical routine to inform diagnosis, prognosis and treatment decisions. At the same time, new tumor entities have been identified that cannot be defined histologically. For central nervous systems tumors, the current World Health Organization classific...
EGAS00001002213 | EGA
Genomicsena-DATASET-ICM-15-06-2017-11:25:49:785-1367 - samples
Description not provided
EGAD00001003382 | EGA
Genomicsena-DATASET-ICM-15-06-2017-21:23:23:822-1522 - samples
Description not provided
EGAD00001003387 | EGA
Genomicsena-DATASET-ICM-19-09-2016-19:27:01:379-11 - samples
Exome sequencing of for 10 patients: 10 tumors, 10 cell lines and 7 blood samples (for 3 patients blood was not available)
EGAD00001002690 | EGA
Genomicsena-DATASET-ICM-19-09-2016-19:29:23:436-12 - samples
RNAseq data for 10 patients: 10 tumors and 10 cell lines
EGAD00001002691 | EGA
GenomicsMulti-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Glioblastoma (GBM) is the deadliest primary brain cancer in adults. Emerging innovative therapies hold promise for personalized cancer treatment. Improving therapeutic options depends on research relying on relevant preclinical models. In this line we have established in the setting of the GlioTeX p...
EGAS00001001871 | EGA
GenomicsGlioTex-ICM
Data Access Committee EGAC00001000513
EGAC00001000513 | EGA
Sort   by:  
 Page size